Hypoxia-selective Radiosensitization of Mammalian Cells by Nitracrine, an Electron-affinic DNA Intercalator
- 1 January 1987
- journal article
- research article
- Published by Taylor & Francis in International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine
- Vol. 51 (4) , 641-654
- https://doi.org/10.1080/09553008414552171
Abstract
The radiosensitizing ability of the 1-nitrocaridine nitracrine (NC) is of interest since it is an example of a DNA intercalating agent with an electron-affinic nitro group. NC radiosensitization was evaluated in Chinese hamster ovary cell (AA8) cultures at 4.degree. C in orer to suppress the rapid metabolism and potent cytotoxicity of the drug. Under hypoxic conditions, submicromolar concentrations of NC resulted in sensitization (SER=1.6 at 1 .mu.mol dm-3). Sensitization was also seen under aerobic conditions but a concentration more than 10-fold higher was required. In aerobic cultures NC radiosensitization was independent of whether cells were exposed before and during, or after, irradiation. Postirradiation sensitization was not observed under hypoxic conditions. The time dependence of NC uptake and the development of radiosensitization were similar (maximal at 30 min at 4.degree. C under hypoxia) suggesting that sensitization, unlike cytotoxicity, is due to unmetabolized drug. NC is about 1700 times more potent as a radiosensitizer than misonidazole. This high potency is adequately accounted for by the electron affinity of NC (E(1) value at pH7 of -275 mV versus NHE) and by its accumulation in cells to give intracellular concentrations approximately 30 times greater than in the medium. However, concentrations of free NC appear to be low in AA8 cells, presumably because of DNA binding. If radiosensitization by NC is due to be bound rather than free drug, it suggests that intercalated NC can interact very efficiently with DNA target radicals. This is despite a binding ration in the cell estimated as less than 1 NC molecule/400 base pairs under conditions providing efficient sensitization. This work suggest a new approach in the search for more effective clinical radiosensitizers, and poses questions on the means by which intercalated drugs can interact with DNA damage.This publication has 28 references indexed in Scilit:
- Considerations for the design of nitrophenyl mustards as agents with selective toxicity for hypoxic tumor cellsJournal of Medicinal Chemistry, 1986
- Primary radiotherapy of larynx and pharynx carcinoma—An analysis of some factors influencing local control and survivalInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancerBiochemical Pharmacology, 1986
- Nitroacridines with selective toxicity towards hypoxic mammalian cells: Synthesis and stability of tritiated derivativesJournal of Labelled Compounds and Radiopharmaceuticals, 1985
- Clinical trials of radiosensitizers: What should we expect?International Journal of Radiation Oncology*Biology*Physics, 1984
- Interactions of some nitro-derivatives of substituted 9-aminoacridine with DNABiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1977
- In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stainExperimental Cell Research, 1977
- Semiquinone free radicals and oxygen. Pulse radiolysis study of one electron transfer equilibriaJournal of the Chemical Society, Faraday Transactions 1: Physical Chemistry in Condensed Phases, 1973
- Spectroscopic studies of reactions of the OH radical in aqueous solutions. Reaction of OH with the ferrocyanide ionTransactions of the Faraday Society, 1965
- Actinomycin D: Suppression of Recovery in X-Irradiated Mammalian CellsScience, 1964